0001225208-15-002820.txt : 20150203
0001225208-15-002820.hdr.sgml : 20150203
20150203161347
ACCESSION NUMBER: 0001225208-15-002820
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150124
FILED AS OF DATE: 20150203
DATE AS OF CHANGE: 20150203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thepaut Eric Francis Yves
CENTRAL INDEX KEY: 0001631992
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 15571247
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
3
1
doc3.xml
X0206
3
2015-01-24
0
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001631992
Thepaut Eric Francis Yves
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
SVP & Pres, Europe
Common Stock
83334.9900
D
Deferred Stock Units
2015-02-16
2015-02-16
Common Stock
4905.0000
D
Deferred Stock Units
2019-02-24
2019-02-24
Common Stock
7645.0000
D
Deferred Stock Units
2017-02-27
2017-02-27
Common Stock
12899.0000
D
Deferred Stock Units
2016-02-28
2016-02-28
Common Stock
6145.0000
D
Deferred Stock Units
2018-02-28
2018-02-28
Common Stock
21652.0000
D
Deferred Stock Units
2016-10-25
2016-10-25
Common Stock
7380.0000
D
Deferred Stock Units
2018-10-29
2018-10-29
Common Stock
6785.0000
D
Deferred Stock Units
2019-12-01
2019-12-01
Common Stock
11636.0000
D
Stock Option (Right to Buy)
7.4700
2021-03-07
Common Stock
32353.0000
D
Stock Option (Right to Buy)
7.7400
2020-02-26
Common Stock
9866.0000
D
Stock Option (Right to Buy)
8.3000
2019-02-24
Common Stock
23458.0000
D
Stock Option (Right to Buy)
12.8900
2024-12-01
Common Stock
30688.0000
D
Stock Option (Right to Buy)
13.0800
2024-02-24
Common Stock
20000.0000
D
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.
This amount represents the unvested portion of DSUs awarded on February 16, 2010, which will continue to vest in one remaining installment on the anniversary of the date of grant.
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
This amount represents the unvested portion of DSUs awarded on February 27, 2012, which will continue to vest in three remaining installments on the anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
This amount represents the unvested portion of DSUs awarded on February 28, 2011, which will continue to vest in two remaining installments on the anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
This amount represents the unvested portion of DSUs awarded on February 28, 2013, which will continue to vest in four remaining installments on the anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 25, 2012, the first anniversary of the date of grant.
This amount represents the unvested portion of DSUs awarded on October 25, 2011, which will continue to vest in two remaining installments on the anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 29, 2014, the first anniversary of the date of grant.
This amount represents the unvested portion of DSUs awarded on October 29, 2013, which will continue to vest in four remaining installments on the anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 1, 2015, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase 32,353 shares of common stock vesting in full on March 7, 2015, the fourth anniversary of the date of grant.
Grant to the reporting person of an option to purchase 9,866 shares of common stock vesting in four equal annual installments beginning on February 26, 2011, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase 23,458 shares of common stock vesting in four equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase 30,688 shares of common stock vesting in four equal annual installments beginning on December 1, 2015, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase 20,000 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
thepautpoa1.txt
/s/ Lee G. Giguere, Attorney-in-Fact
2015-02-03
EX-24
2
thepautpoa1.txt
POWER OF ATTORNEY
Know all by these present that the undersigned hereby constitutes
and appoints each of Timothy A. Pratt, Vance R. Brown, Scott G. Hodgdon
and Lee G. Giguere signing singly, the undersigned's true and lawful
attorney-in-fact to:
(1) prepare and execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities and Exchange
Commission (the "SEC") a Form ID, including amendments thereto, and
any other documents necessary or appropriate to obtain codes and
passwords enabling the undersigned to make electronic filings with
the SEC of reports required by Section 16(a) of the Securities Exchange
Act of 1934, as amended, or any rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned, in the
undersigned's capacity as an executive officer and/or director
of Boston Scientific Corporation (the "Company"), Forms 3, 4 and 5,
and amendments thereto, in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended, and the rules thereunder;
(3) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Form 3, 4 or 5 and file such form with the SEC
and any stock exchange or similar authority;
(4) execute for and on behalf of the undersigned, in the
undersigned's capacity as an executive officer and/or director
of the Company, Forms 144 in accordance with Rule 144 of the
Securities Act of 1933, as amended, and the rules and regulations
thereunder; and
(5) take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-fact,
may be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act and
thing whatsoever requisite, necessary, or proper to be done in
the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution
or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue
of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request
of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, as
amended, or Rule 144 of the Securities Act of 1933, as amended.
This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file
Forms 3, 4 and 5 and Forms 144 with respect to the undersigned's
holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 26th day of January, 2015.
/s/ Eric Francis Yves Thepaut
_____________________________
Eric Francis Yves Thepaut